Key Financial’s Lantern Pharma LTRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2 Hold
2
– – ﹤0.01% 1311
2026
Q2
$8 Hold
2
– – ﹤0.01% 1353
2026
Q1
$3 Hold
2
– – ﹤0.01% 1393
2025
Q4
$6 Hold
2
– – ﹤0.01% 1439
2025
Q3
$8 Hold
2
– – ﹤0.01% 1457
2025
Q2
$6 Buy
+2
New +$7 ﹤0.01% 1435

Other funds holding LTRN

Key Financial's LTRN Position: Q3 2026 in Review

Key Financial held its Lantern Pharma (LTRN) position steady in Q3 2026 at 2 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #1311.

Key Financial first reported a position in LTRN in Q2 2025 and has held it in 6 quarters since. The position peaked at $8 in Q2 2026. 36 funds tracked by Wall St. Rank hold LTRN as of Q3 2026.

  • Key Financial held 2 shares of Lantern Pharma worth $2 as of Q3 2026.
  • Key Financial left its Lantern Pharma share count unchanged in Q3 2026.
  • Lantern Pharma made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1311 holding.
  • Key Financial first reported a position in Lantern Pharma in Q2 2025 and has held it in 6 quarters since.
  • Key Financial's Lantern Pharma position peaked at $8 in Q2 2026.
  • 36 funds tracked by Wall St. Rank held Lantern Pharma as of Q3 2026.

Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.